US ocular gene therapy company, Avalanche Biotechnologies, raises $55M in a Series B fund-raising
Avalanche Biotechnologies, an ocular gene therapy company based in Menlo Park California, have announced the completion of a $55M fund raising. The company will use… Read More »US ocular gene therapy company, Avalanche Biotechnologies, raises $55M in a Series B fund-raising